Грибковые аллергены и диагностика аллергии к плесневым грибам

Иммунология – раздел медицины, изучающий иммунную систему и ее патологию. Общеизвестна научная информация о том, что в медицинской иммунологии специальные лабораторные тесты предназначены для диагностики иммунопатологии. Наряду с этим следует отметить, что для диагностики аллергии применяют такие рутинные методы диагностики, как анализ клеток крови. Также для диагностики аллергии используется количественное определение иммуноглобулинов класса IgE. В настоящем обзоре авторы имели цель обсудить некоторые аспекты, относящиеся к грибковым аллергенам и диагностике аллергии на плесневые грибы. Плесневые грибы вырабатывают микотоксины, которые, к сожалению, обладают канцерогенными, тератогенными и нейротоксическими свойствами, что может негативно сказаться на здоровье человека. Аллергия на грибы и сопутствующие заболевания в основном касаются пациентов с ослабленным иммунитетом. Накопленные в настоящее время знания в области аллергии на грибковые аллергены и людей, а также установленная диагностика и лечение предлагают нам комплексное видение. В будущем мы надеемся найти в научных исследованиях надлежащие знания в этой области, применимые в повседневной практике.

1. A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation I /S. Dreborg, B. Agrell, T. Foucard //Clinical results. Allergy. – 1986. – V. 41 (2). – P. 131-140.

2. Aalberse R. C. Structural biology of allergens //J. Allergy Clin. Immunol. – 2000. – V. 106. – P. 228-238.

3. Allergens produce serine proteasesdependent distinct release of metabolite DAMPs in human bronchial epithelial cells /S. Ramu, M. Menzel, L. Bjermer //Clin. Exp. Allergy. – 2018. – V. 48 (2). – P. 156-166.

4. Allergic Fungal Airway Disease /E. M. Rick, K. Woolnough, C. H. Pashley, A. J. Wardlaw // J. Investig. Allergol. Clin. Immunol. – 2016. – V. 26 (6). P. 344-354.

5. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the world health organization, GA(2)LEN and llerGen) / J. Bousquet, N. Khaltaev, A. A. Cruz et al. //Allergy. – 2008. – V. 63, Suppl. 86. – P. 8-16.

6. Allergic rhinitis and its impact on asthma (ARIA) guidelines – 2016 revision /J. L. Brozek, J. Bousquet, I. Agache et al. //J. Allergy Clin. Immunol. – 2017. – V. 140. – P. 950-958.

7. Anagnostou K. Anaphylaxis in Children: Epidemiology, Risk Factors and Management //Curr. Pediatr. Rev. – 2018. – V. 14 (3). – P. 180-186.

8. Anaphylaxis – Causes, therapy and prevention /L. Klimek, A. Sperl, M. Worm, J. Ring // MMW Fortschr. Med. – 2017. – V. 159, Suppl. 3. – P. 76-84.

9. Anaphylaxis: incidence, presentation, causes and outcome in patients in a tertiary-care hospital in Karachi, Pakistan /N. U. Khan, N. Shakeel, A. Makda et al. //QJM. – 2013. – V. 106 (12). – P. 1095-1101.

10. Basophil biomarkers as useful predictors for sublingual immunotherapy in allergic rhinitis /M. Caruso, F. Cibella, R. Emma et al. //Int. Immunopharmacol. – 2018. – V. 60. – P. 50-58.

11. Biological occupational allergy: Protein microarray for the study of laboratory animal allergy (LAA) /M. C. D'Ovidio, A. Wirz, D. Zennaro et al. // AIMS Public Health. – 2018. – V. 5 (4). – P. 352-365.

12. Borgeat Kaeser A. Where are we with oral immunotherapy for food allergy? /A. Borgeat Kaeser, L. Moi, F. Spertini //Rev. Med. Suisse. – 2019. – V. 632. – P. 20-22.

13. Burden of allergic rhinitis: results from the pediatric allergies in america survey /E. O. Meltzer, M. S. Blaiss, M. J. Derebery et al. /J. Allergy Clin. Immunol. – 2009. – V. 124. – P. 43-70.

14. Church M. K. Pharmacology of antihistamines /M. K. Church, D. S. Church //Indian J. Dermatol. – 2013. – V. 58. – P. 219.

15. Colleti J. The First-Line Treatment of Anaphylaxis Is to Have a Written Protocol /J. Colleti, W. Brunow de Carvalho //Pediatr. Crit. Care. Med. – 2017. – V. 18 (11). – P. 1088-1089.

16. D'Amato G. Aerobiologic and clinical aspects of mould allergy in Europe /G. D'Amato, F. T. Spieksma //Allergy. – 1995. – V. 50 (11). – P. 870-877.

17. Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract /M. Horst, A. Hejjaoui, V. Horst et al. //J. Allergy Clin. Immunol. – V. 1990. – V. 85. P. 460-472.

18. Dziadzio L. Assessment and control of fungal allergens /L. Dziadzio, R. K. Bush //Curr. Allergy Asthma Rep. – 2001. – V. 1 (5). – P. 455-460.

19. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group / P. Lieberman, C. A. Camargo, K. Bohlke et al. // Ann. Allergy Asthma Immunol. – 2006. – V. 97 (5). – P. 596-602.

20. Evaluation of 'Definite' Anaphylaxis Drug Allergy Alert Overrides in Inpatient and Outpatient Settings /A. Wong, D. L. Seger, S. P. Slight et al. // Drug Saf. – 2018. – V. 41 (3). – P. 297-302.

21. Fcepsilonri expression and ige binding by dendritic cells and basophils in allergic rhinitis and upon allergen immunotherapy /M. Berings, P. Gevaert, N. De Ruyck et al. //Clin. Exp. Allergy. – 2018. – V. 48. – P. 970-980.

22. Fungi: the neglected allergenic sources /R. Crameri, M. Garbani, C. Rhyner, C. Huitema // Allergy. – 2014. – V. 69 (2). – P. 176-185.

23. Ga Len; Allergen. Allergic Rhinitis and Its Impact on Asthma (ARIA) /J. Bousquet, N. Khaltaev, A. Cruz et al. – Geneva: World Health Organization, 2008. – 56 p.

24. Gawlik R. Swoista immunoterapia w alergii na grzyby pleśniowe w świetle EBM //Alergologia Współczesna. – 2008. – V. 1 (21). – P. 16-18.

25. Global map of the prevalence of symptoms of hinoconjunctivitis in children: the international study of asthma and allergies in childhood (ISAAC) phase three /N. Aït-Khaled, N. Pearce, H. R. Anderson et al. //Allergy. – 2009. – V. 64. – P. 123-148.

26. Golden D. B. Anaphylaxis: Recognizing Risk and Targeting Treatment //J. Allergy Clin. Immunol. Pract. – 2017. – V. 5 (5). – P. 1224-1226.

27. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD) /O. Pfaar, C. Bachert, A. Bufe et al. //Allergo J. Int. – 2014. – V. 23 (8). – P. 282-319.

28. Hosseini S., Shoormasti R. S., Akramian R. et al. Skin prick test reactivity to common aero and food allergens among children with allergy // Iran. J. Med. Sci. – 2014. – V. 39. – P. 29-35.

29. House dust mite sensitization is the main risk factor for the increase in prevalence of wheeze in 13- to 14-year-old school children in Guangzhou city, China /J. Li, H. Wang, Y. Chen et al. //Clin. Exp. Allergy. – 2013. – V. 43. – P. 1171-1179.

30. Immune complexes exposed on mast cellderived nanovesicles amplify allergic inflammation /R. Molfetta, M. Lecce, L. Quatrini et al. //Allergy. – 2020. – V. 75 (5). – P. 1260-1263.

31. International consensus on allergy immunotherapy /M. Jutel, I. Agache, S. Bonini et al. //J. Allergy Clin. Immunol. – 2015. –V. 136 (3) – P. 556-568.

32. Justiz Vaillant A. A. Immediate Hypersensitivity Reactions /A. A. Justiz Vaillant, R. Vashisht, P. M. Zito //StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Aug 25, 2022.

33. M2 macrophages correlated with symptom severity and promote type 2 inflammation in allergic rhinitis /H. Lou, Y. Huang, H. Chen et al. //Allergy. – 2019. – V. 74. – P. 2255-2257.

34. Malling H. J. Diagnosis and immunotherapy of mould allergy. V. Clinical efficacy and side effects of immunotherapy with Cladosporium herbarum / H. J. Malling, S. Dreborg, B. Weeke //Allergy. – 1986. – V. 41. – P. 507-519.

35. Mal'tsev D. V. The revised Gell and Coombs classification: a new reading of old truths in the context of immunodeficiencies theory /D. V. Mal'tsev, V. E. Kazmirchuk, V. V. Tsarik //Lik. Sprava. – 2012. – V. 1-2. – P. 28-44.

36. McKay M. P. 23 years of toxicology testing fatally injured pilots: implications for aviation and other modes of transportation /M. P. McKay, L. Groff // Accid. Anal. Prev. – 2016. – V. 90. – P. 108-117.

37. Mechanisms, Cofactors, and Augmenting Factors Involved in Anaphylaxis /R. Muñoz-Cano, M. Pascal, G. Araujo et al. //Front Immunol. – 2017. – V. 8. – P. 1193.

38. Modern life makes children allergic. A crosssectional study: associations of home environment and lifestyles with asthma and allergy among children in Tianjin region, China /Y. Sun, J. Hou, Y. Sheng et al. //Int. Arch. Occup. Environ. Health. – 2019. – V. 92 (4). – P. 587-598.

39. Multiple-cytokine profiling: a novel method for early prediction of the efficacy of sublingual immunotherapy in allergic rhinitis patients /Y. Zhang, K. Zhu, C. Xia et al. //J. Inflamm. Res. – 2022. – V. 15. – P. 603-612.

40. Nasal epithelial barrier dysfunction increases sensitization and mast cell degranulation in the absence of allergic inflammation /K. I. Kortekaas, S. F. Seys, G. Lund et al. //Allergy. – 2020. – V. 75. – P. 1155-1164.

41. Naz S. Angioedema; An Unreported Adverse Effect Of Pitavastatin /S. Naz, M. W. Saleem, A. W. Haider //J. Ayub. Med. Coll. Abbottabad. – 2018. – V. 30 (4). – P. 603-604.

42. Pediatric allergy and immunology in Spain /A. Nieto, A. Mazon, M. A. Martin-Mateos et al. //Pediatr. Allergy Immunol. – 2011. – V. 22. – P. 742-750.

43. Ring J. History of Allergy: Clinical Descriptions, Pathophysiology, and Treatment //Exp. Pharmacol. – 2022. – V. 268. – V. 3-19.

44. Risk factors for severe anaphylaxis in the United States /M. S. Motosue, M. F. Bellolio, H. K. Van Houten et al. //Ann. Allergy Asthma Immunol. – 2017. – V. 119 (4). – P. 356-361.

45. Sensitization to fungi: epidemiology, comparative skin tests, and IgE reactivity of fungal extracts /A. Mari, P. Schneider, V. Wally et al. //Clin. Exp. Allergy. – 2003. – V. 33 (10). P. 1429-1438.

46. The clinical differences of asthma in patients with molds allergy /K. Kołodziejczyk, A. Bożek, J. Jarząb, R. Gawlik //Pneumonol. Alergol. Pol. – 2016. – V. 84 (2). – P. 81-86.

47. The Journal of Allergy and Clinical Immunology: In Practice 2018 Highlights /M. Schatz, S. H. Sicherer, D. Khan, R. S. Zeiger //J. Allergy Clin. Immunol. Pract. – 2019. – V. 7 (2). – P. 393-411.

48. WAO White Book on Allergy /R. Pawankar, S. T. Holgate, W. Canonica. – Wisconsin, 2013. – 30 p.

49. Zonula occludens-1 expression is reduced in nasal epithelial cells of allergic rhinitis patients /O. S. S. Che, M. N. H. Siti, M. S. Norasnieda, K. W. Kah / Peer J. – 2022. – V. 22, 10. – e13314.